What is the rate of pneumothorax (collapsed lung) for Computed Tomography (CT)-guided hilar lung mass biopsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pneumothorax Rate for CT-Guided Hilar Lung Mass Biopsy

CT-guided biopsy of hilar lung masses carries a pneumothorax risk of approximately 20-25%, with 3-6% requiring chest tube drainage, and perihilar location specifically increases the risk of pneumothorax due to the greater distance of aerated lung that must be traversed. 1

Overall Pneumothorax Rates for CT-Guided Lung Biopsy

The pneumothorax rate for CT-guided lung biopsies ranges broadly from 0-61% across all lesion locations, reflecting differences in lesion characteristics, detection methods, and technical factors. 1 However, more clinically relevant rates from national survey data show:

  • Overall pneumothorax rate: 20.5% of all lung biopsies 1
  • Pneumothorax requiring chest tube drainage: 3.1-3.3% 1
  • Mortality rate: 0.15% 1

Recent meta-analyses report similar findings, with pooled pneumothorax rates of 19-25.3% for CT-guided procedures, and chest tube insertion required in 1.8-5.7% of cases. 1

Specific Risk for Hilar Masses

Perihilar and hilar biopsies carry distinctly higher pneumothorax risk compared to peripheral lesions. 1 The key mechanism is that the needle must traverse a greater distance of aerated lung tissue to reach centrally located hilar masses. 1

In a specific series of CT-guided biopsies of hilar masses after negative bronchoscopy, the pneumothorax rate was 25%, with only 5% (1 patient) requiring chest tube placement. 2 This demonstrates that while pneumothorax occurs frequently with hilar biopsies, most cases are small and self-limited.

Risk Factors That Increase Pneumothorax Rates

Beyond hilar location, several factors compound pneumothorax risk:

  • Lesion not abutting the pleura - significantly increases risk 1
  • Smaller lesion size - independent risk factor (OR 0.724 per cm decrease) 3
  • Longer needle tract through aerated lung - independent risk factor (OR 1.320 per cm) 3
  • Multiple pleural punctures - increases risk substantially (OR 3.7-4.6) 4, 3
  • Emphysema along biopsy path - independent risk factor 1, 4
  • Nodule distance >4 cm from pleural surface - increases risk 1, 5

Core Needle vs Fine Needle Aspiration

Core needle biopsies (18-20 gauge) have higher pneumothorax rates than fine needle aspiration (FNA). 1 Specifically:

  • Core needle biopsy: 25.3% pneumothorax rate, 5.6% requiring intervention 1
  • FNA: 18.8% pneumothorax rate, 4.3% requiring intervention 1

However, a single-institution study found no significant difference between 18-gauge and 20-gauge needles (25.6% vs 28.7% pneumothorax rates). 1, 5

Detection Method Affects Reported Rates

The wide range of reported pneumothorax rates (0-61%) partially reflects CT's superior sensitivity compared to chest radiography for detecting small pneumothoraces. 1

  • CT detects pneumothorax in 40% of cases 6
  • Chest radiography detects only 25% of the same cases 6
  • Average pneumothorax depth on CT: 7.3 mm when visible on CXR vs 3.4 mm when CXR-negative 6

Delayed Pneumothorax

Delayed pneumothorax occurs in 4.9% of cases and carries a significantly higher rate of chest tube insertion compared to immediate pneumothorax. 4 Risk factors specific to delayed pneumothorax include:

  • Upper lobe location (OR 5.756) 4
  • Multiple pleural punctures (OR 3.738) 4
  • Smaller lesion size (OR 0.610) 4

Clinical Implications for Hilar Mass Biopsy

When counseling patients about CT-guided biopsy of hilar masses, inform them of:

  • 1 in 4-5 chance (20-25%) of developing pneumothorax 1, 2
  • 1 in 20-30 chance (3-6%) of requiring chest tube placement 1, 2
  • Very low mortality risk (0.15%) 1

Consider bronchoscopic approaches first for hilar masses, as CT-guided transthoracic biopsy may be reserved for cases where bronchoscopy is non-diagnostic or the lesion is deemed inaccessible bronchoscopically. 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.